Analyst Ratings for Coherus Biosciences (CHRS)
CHRS Rating Summary
CHRS Price Target Summary
- Highest: $10.00 (Oppenheimer)
- Lowest: $4.00 (Maxim Group)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.00 (+284.6%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 82%
Avg. $ Target:
$7.00 (+284.6%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/23/2026 | Oppenheimer » Updated 2/4/2026 |
Jay Olson | New Coverage | Outperform (N/A) |
10.00 (N/A) |
1.64 (1.82) |
10.98% | Details |
| 9/4/2025 | Maxim Group | Jason McCarthy | Upgrade | Buy (Hold) |
4.00 (N/A) |
1.26 (1.82) |
44.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
